CRP and cardiomyopathy: Figure 5 shows the bar graph comparing semaglutide vs. placebo effects on Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS, points), weight loss (%), 6-minute walk test (6MWT) distance (meters), and C-reactive protein (CRP) reduction (%) in the STEP HFpEF (n = 529) and STEP HFpEF DM (n = 616) trials.